Modern Drug Discovery & Development Summit 2012

Productivity in the pharmaceutical industry is lagging. It is now clear that the traditional pharmaceutical research and development model is not sustainable. New technological innovations may mitigate the situation, but they will not sufficiently reverse the inexorable decline in productivity to salvage the traditional R&D model. Instead, radically different research business models must be developed, tested and implemented. Failure to do so poses a grave threat to the future of the pharmaceutical industry.

Despite such a challenge, new government regulation in areas such as stem cell research and recent advances in technology, as seen in transitional medicine, do present the industry with opportunities to push forward and prosper. Exploring these future opportunities is at the center of the 8th Modern Drug Discovery & Development (M3D) Summit in Philadelphia, PA on October 24-26, 2012.

Dedicated networking events have been incorporated to enhance the exchange of information between technology developers and end-users. The M3D will provide a great opportunity for companies to expose products and services.

• Keynote Speakers
Harsukh Parmar,Morten Sogaard,Anthony J. Coyle,John C. McKew,Barry Morgan,Glenn D. Prestwich